Work

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Year: 2010

Type: article

Study design: Clinical Trial

Source: Cephalalgia

DOI: 10.1177/0333102410364677

Authors: HC Diener, DW Dodick, SK Aurora, CC Turkel, RE DeGryse, RB Lipton, SD Silberstein, MF Brin

Institutions: University of Duisburg-Essen, Mayo Clinic in Arizona, Allergan (United States), Albert Einstein College of Medicine, Thomas Jefferson University, University of California, Irvine

Language: English

Topic: Migraine and Headache Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4230120862

FWCI: 31.24

Cites: 44

Cited by: 979

Related to: 10